Nezam Afdhal is an Internal Medicine provider in Boston, Massachusetts. Dr. Afdhal is rated as an Elite provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis C, Hepatitis, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Endoscopy.

Dr. Oluwaseun O. Falade-Nwulia is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include infectious disease. Dr. Falade-Nwulia earned her M.B.B.S. from the University of Ibadan Medical School College of Medicine. She completed her residency at Johns Hopkins Bayview Medical Center. She performed fellowships in infectious diseases at Johns Hopkins and a fellowship in critical care medicine at the National Institutes of Health. Dr. Falade is rated as an Elite provider by MediFind in the treatment of Hepatitis C. Her top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Sepsis.

Dr. Christine Durand, associate professor of medicine and oncology and member of the Johns Hopkins Kimmel Cancer Center, is involved in clinical and translational research focused on individuals infected with HIV and hepatitis C virus who require cancer and transplant therapies. Her current research efforts include looking at outcomes of hepatitis C treatment after solid organ transplant, the potential use of organs from HIV-infected donors for HIV-infected solid organ transplant candidates, and HIV cure strategies including bone marrow transplantation. Dr. Durand is rated as an Elite provider by MediFind in the treatment of Hepatitis C. Her top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, Tissue Biopsy, and Nephrectomy.

Dr. Andrea L. Cox is a professor of Internal Medicine at the Johns Hopkins University School of Medicine in the Division of Infectious Diseases and is a member of the Johns Hopkins Kimmel Cancer Center. She holds joint appointments in Oncology and at the Johns Hopkins Bloomberg School of Public Health, in Molecular Microbiology and Immunology. She is an internationally recognized leader in studies of immune responses in immunocompetent and immunocompromised patient populations to viral infections and vaccines against them, including SARS-Co-V-2 (the virus that causes COVID-19), HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV). Dr. Cox earned her Ph.D. in chemistry from the University of Virginia, where she characterized peptides that drive T cell responses. She then earned her M.D. and completed internal medicine residency and infectious disease fellowship training at Johns Hopkins. She leads the largest prospective cohort study of acute HCV infection, designed to enable detailed molecular analysis of HCV transmission, host immune responses, and virus sequence evolution. She co-led the first prophylactic HCV vaccine trial in individuals at risk of HCV infection. She leads a multidisciplinary international team investigating HCV-specific immune responses to improve vaccine development against HCV, is the lead immunologist on a clinical trial of HBV vaccines in people living with HIV, and co-leads a large team investigating immune responses to COVID-19 infection and vaccines. In addition to her research on viral infections and vaccines, Dr. Cox is actively involved in clinical care of patients with HCV, HIV, and HBV infections. Dr. Cox serves as the director of the Medical Scientist Training Program. A teacher, advisor, and mentor of physician-scientists and scientists, Dr. Cox mentors Ph.D. students in the Johns Hopkins Cellular and Molecular Medicine, Molecular Microbiology and Immunology, and the Immunology graduate training programs. Dr. Cox is rated as an Elite provider by MediFind in the treatment of Hepatitis C. Her top areas of expertise are Hepatitis C, Hepatitis, Severe Acute Respiratory Syndrome (SARS), and COVID-19.

Dr. Akiyama is an Associate Professor of Medicine and Clinician-Investigator in the Divisions of General Internal Medicine and Infectious Diseases. In addition to providing care and treatment to people living with HIV, hepatitis C virus (HCV), and substance use disorders, Dr. Akiyama conducts research focusing on HCV among socioeconomically marginalized populations with particular emphasis on the intersection of HCV in the criminal legal system and sub-Saharan Africa. Dr. Akiyama is the recipient of a K99/R00 award from the National Institute on Drug Abuse to develop and test an innovative strategy to improve linkage to and retention in HCV treatment among individuals recently released from jail. He is also the recipient of an Avenir Award from the National Institute on Drug Abuse focused on HCV Transmission Networks Among People Who Inject Drugs. Dr. Akiyama is rated as an Elite provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Severe Acute Respiratory Syndrome (SARS).

. Dr. Feyssa is rated as a Distinguished provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis, Hepatitis C, Visceromegaly, Liver Transplant, and Endoscopy.

. Dr. Riera is rated as a Distinguished provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis, Visceromegaly, Hepatitis C, Enlarged Liver, and Liver Embolization.

George Therapondos is a Hepatologist in New Orleans, Louisiana. Dr. Therapondos is rated as an Elite provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis, Hepatitis C, Cirrhosis, Liver Transplant, and Endoscopy. Dr. Therapondos is currently accepting new patients.

Sammy Saab is a Hepatologist in Los Angeles, California. Dr. Saab is rated as an Elite provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis C, Hepatitis, Ascites, Liver Transplant, and Liver Embolization.

Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine and is the Senior Associate Dean for Clinical Trials. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995) and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine. Prof. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He was the global principal investigator for more than a dozen trials, including the largest clinical trial of agents for the treatment of hepatitis C (New England Journal of Medicine, 2009) and the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation (2011) and the American Association of Physicians (2017). Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. In 2017, 2018 and 2019, he was named as a Highly Cited Researcher (Clarivate Analytics) defined as the being in the top 1% of global researchers in 21 fields of the sciences and social sciences based on the number of citations for papers. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries. Dr. Sulkowski is rated as an Elite provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B.

Stefan Zeuzem practices in Frankfurt Am Main, Germany. Mr. Zeuzem is rated as an Elite expert by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis C, Hepatitis, Cirrhosis, Liver Transplant, and Gastrostomy.

Norah Terrault is a Gastroenterologist in Los Angeles, California. Dr. Terrault is rated as an Elite provider by MediFind in the treatment of Hepatitis C. Her top areas of expertise are Hepatitis, Hepatitis C, Hepatitis B, Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

Jordan Feld practices in Toronto, Canada. Mr. Feld is rated as an Elite expert by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis, Hepatitis C, Hepatitis B, Liver Transplant, and Lung Transplant.

Paul Kwo is a Gastroenterologist in Stanford, California. Dr. Kwo is rated as an Elite provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis C, Hepatitis, Cirrhosis, Liver Transplant, and Hormone Replacement Therapy (HRT).

Jason Grebely practices in Kensington, Australia. Mr. Grebely is rated as an Elite expert by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B.

Heiner Wedemeyer is a Hepatologist in Hannover, Germany. Mr. Wedemeyer is rated as an Elite expert by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis D, Hepatitis, Hepatitis C, Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

Lai Wei is a Hepatologist in Changping, China. Mr. Wei is rated as an Elite expert by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis C, Hepatitis, Hepatitis B, Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

Gregory Dore practices in Darlinghurst, Australia. Mr. Dore is rated as an Elite expert by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis C, Hepatitis, Hepatitis B, HIV/AIDS, and Hormone Replacement Therapy (HRT).

Raymond Chung is a Gastroenterologist in Waltham, Massachusetts. Dr. Chung is rated as an Elite provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis, Hepatitis C, Cirrhosis, Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

I am proud to serve as the Chief of the Duke Division of Gastroenterology. In addition to my administrative duties, I enjoy my clinical practice focused on the care of patients with liver diseases. I also continue to participate in clinical research and hope that these studies offer our patients the latest advances and treatment options. Dr. Muir is rated as an Elite provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis C, Hepatitis, Sclerosing Cholangitis, Liver Transplant, and Kidney Transplant.